Logo image of NMAX

NEWSMAX INC (NMAX) Stock Fundamental Analysis

NYSE:NMAX - New York Stock Exchange, Inc. - US65250K1051 - Common Stock - Currency: USD

23.25  +0.52 (+2.29%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NMAX. NMAX was compared to 96 industry peers in the Media industry. NMAX may be in some trouble as it scores bad on both profitability and health. NMAX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NMAX has reported negative net income.
NMAX had a negative operating cash flow in the past year.
NMAX Yearly Net Income VS EBIT VS OCF VS FCFNMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

NMAX has a worse Return On Assets (-54.89%) than 88.54% of its industry peers.
Industry RankSector Rank
ROA -54.89%
ROE N/A
ROIC N/A
ROA(3y)-53.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NMAX Yearly ROA, ROE, ROICNMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 200 -200 400 600 800

1.3 Margins

Looking at the Gross Margin, with a value of 49.15%, NMAX is in the better half of the industry, outperforming 61.46% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for NMAX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NMAX Yearly Profit, Operating, Gross MarginsNMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40 -40

More info and screens

2

2. Health

2.1 Basic Checks

NMAX does not have a ROIC to compare to the WACC, probably because it is not profitable.
NMAX has about the same amout of shares outstanding than it did 1 year ago.
NMAX has a better debt/assets ratio than last year.
NMAX Yearly Shares OutstandingNMAX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
NMAX Yearly Total Debt VS Total AssetsNMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M

2.2 Solvency

NMAX has an Altman-Z score of 8.64. This indicates that NMAX is financially healthy and has little risk of bankruptcy at the moment.
NMAX has a Altman-Z score of 8.64. This is amongst the best in the industry. NMAX outperforms 93.75% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 8.64
ROIC/WACCN/A
WACC9.12%
NMAX Yearly LT Debt VS Equity VS FCFNMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 -20M -40M

2.3 Liquidity

NMAX has a Current Ratio of 0.96. This is a bad value and indicates that NMAX is not financially healthy enough and could expect problems in meeting its short term obligations.
NMAX's Current ratio of 0.96 is on the low side compared to the rest of the industry. NMAX is outperformed by 67.71% of its industry peers.
A Quick Ratio of 0.95 indicates that NMAX may have some problems paying its short term obligations.
With a Quick ratio value of 0.95, NMAX is not doing good in the industry: 64.58% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.95
NMAX Yearly Current Assets VS Current LiabilitesNMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for NMAX have decreased strongly by -68.55% in the last year.
Looking at the last year, NMAX shows a very strong growth in Revenue. The Revenue has grown by 26.42%.
EPS 1Y (TTM)-68.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-68.55%
Revenue 1Y (TTM)26.42%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%26.42%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NMAX Yearly Revenue VS EstimatesNMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 50M 100M 150M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NMAX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NMAX Price Earnings VS Forward Price EarningsNMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NMAX Per share dataNMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NMAX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEWSMAX INC

NYSE:NMAX (5/22/2025, 10:19:49 AM)

23.25

+0.52 (+2.29%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change0%
Market Cap2.98B
AnalystsN/A
Price TargetN/A
Short Float %2.08%
Short Ratio0.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 17.43
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.63
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)-0.38
OCFYN/A
SpS1.33
BVpS-0.07
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -54.89%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.15%
FCFM N/A
ROA(3y)-53.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.14%
Cap/Sales 0.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.96
Quick Ratio 0.95
Altman-Z 8.64
F-Score5
WACC9.12%
ROIC/WACCN/A
Cap/Depr(3y)90.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.87%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-68.55%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.42%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%26.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-229.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-946.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1170.71%
OCF growth 3YN/A
OCF growth 5YN/A